3,4-ethylenedioxypyrrole
3,4-ethylenedioxypyrrole structure
|
Common Name | 3,4-ethylenedioxypyrrole | ||
|---|---|---|---|---|
| CAS Number | 169616-17-5 | Molecular Weight | 125.125 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 256.9±19.0 °C at 760 mmHg | |
| Molecular Formula | C6H7NO2 | Melting Point | -108ºC | |
| MSDS | Chinese USA | Flash Point | 94.0±11.8 °C | |
| Symbol |
GHS02, GHS07, GHS08 |
Signal Word | Danger | |
| Name | 3,6-dihydro-2H-[1,4]dioxino[2,3-c]pyrrole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 256.9±19.0 °C at 760 mmHg |
| Melting Point | -108ºC |
| Molecular Formula | C6H7NO2 |
| Molecular Weight | 125.125 |
| Flash Point | 94.0±11.8 °C |
| Exact Mass | 125.047676 |
| PSA | 34.25000 |
| LogP | 0.41 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.564 |
| Symbol |
GHS02, GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H302-H319-H335-H351 |
| Supplemental HS | May form explosive peroxides. |
| Precautionary Statements | P210-P280-P301 + P312 + P330-P305 + P351 + P338-P370 + P378-P403 + P235 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | F:Flammable;Xi:Irritant; |
| Risk Phrases | R11;R19;R36/37 |
| Safety Phrases | S16-S26-S29-S33-S36 |
| RIDADR | UN 2056 |
|
~58%
3,4-ethylenedio... CAS#:169616-17-5 |
| Literature: Merz; Schropp; Dotterl Synthesis, 1995 , # 7 p. 795 - 800 |
|
~%
3,4-ethylenedio... CAS#:169616-17-5 |
| Literature: Synthesis, , # 7 p. 795 - 800 |
|
~%
3,4-ethylenedio... CAS#:169616-17-5 |
| Literature: Synthesis, , # 7 p. 795 - 800 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
|
An electrically controlled drug delivery system based on conducting poly(3,4-ethylenedioxypyrrole) matrix.
Bioelectrochemistry 108 , 13-20, (2016) As numerous therapeutic agents are not well tolerated when administrated systemically, localized and controlled delivery can help to decrease their toxicity by applying an optimized drug concentration... |
|
|
Thomas, C.; Zong, K.;Schottland, P.;Reynolds, J.;
Adv. Mater. 12 , 222, (2000)
|
|
|
Gaupp,C.; Reynolds, J.; et.al.
Macromolecules 33 , 1132, (2000)
|
| EDOP |
| 3,4-ethylenedioxypyrrole |
| I11-1121 |
| 6H-1,4-Dioxino[2,3-c]pyrrole, 2,3-dihydro- |
| 2,3-Dihydro-6H-[1,4]dioxino[2,3-c]pyrrole |
| AC-6196 |